Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,872 | -53,077 | -26,165 | -101,886 | -82,616 |
| Depreciation Amortization | 18,038 | 10,852 | 5,177 | 18,011 | 13,689 |
| Accounts receivable | -1,893 | 2,098 | 6,219 | -7,404 | 459 |
| Accounts payable and accrued liabilities | 1,587 | 1,334 | -2,018 | -1,384 | -3,117 |
| Other Working Capital | -5,923 | 2,559 | 4,425 | -6,770 | -13,784 |
| Other Operating Activity | 3,190 | -279 | -2,001 | 21,291 | 14,632 |
| Operating Cash Flow | $-61,873 | $-36,513 | $-14,363 | $-78,142 | $-70,737 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -333,348 |
| PPE Investments | -11,261 | -8,053 | -4,531 | -27,194 | -20,249 |
| Net Acquisitions | N/A | N/A | N/A | 22,450 | 22,450 |
| Purchase Of Investment | -150,327 | -125,075 | -49,633 | -534,717 | -28 |
| Sale Of Investment | 273,835 | 203,415 | 81,837 | 397,807 | 183,460 |
| Investing Cash Flow | $112,247 | $70,287 | $27,673 | $-141,654 | $-147,715 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 305,645 | N/A | N/A | 4,399 | 3,666 |
| Debt Repayment | -72,686 | -1,290 | -838 | -8,347 | -9,753 |
| Common Stock Issued | 41,831 | 5,843 | 2,987 | 211,362 | 206,454 |
| Financing Cash Flow | $274,790 | $4,553 | $2,149 | $207,414 | $200,367 |
| Exchange Rate Effect | -11 | -16 | -7 | N/A | N/A |
| Beginning Cash Position | 32,064 | 32,064 | 32,064 | 44,446 | 44,446 |
| End Cash Position | 357,217 | 70,375 | 47,516 | 32,064 | 26,361 |
| Net Cash Flow | $325,153 | $38,311 | $15,452 | $-12,382 | $-18,085 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,873 | -36,513 | -14,363 | -78,142 | -70,737 |
| Capital Expenditure | -11,261 | -8,053 | -4,531 | -27,194 | -20,291 |
| Free Cash Flow | -73,134 | -44,566 | -18,894 | -105,336 | -91,028 |